Generic Name: Tesamorelin
Brand Name: Egrifta
Manufacturer: Theratechnologies Inc.
Therapeutic Area: Lipodystrophy, HIV-infected patients
Indications: Lipodystrophy, HIV-infected patients
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: August 24, 2016
Recommendation Type: Do not reimburse